Cargando…
Quality of life and depression in Wilson’s disease: a large prospective cross-sectional study
BACKGROUND: Wilson's disease (WD) is an autosomal recessive genetic disorder due to a mutation of the ATP7B gene, resulting in impaired hepatic copper excretion and accumulation in various tissues. Lifelong decoppering treatments are the keystone of the treatment. These treatments can prevent,...
Autores principales: | Chevalier, Kevin, Rahli, Djamila, de Veyrac, Louise, Guillaume, Jessica, Obadia, Michaël Alexandre, Poujois, Aurélia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308610/ https://www.ncbi.nlm.nih.gov/pubmed/37386576 http://dx.doi.org/10.1186/s13023-023-02777-4 |
Ejemplares similares
-
Eye Involvement in Wilson’s Disease: A Review of the Literature
por: Chevalier, Kevin, et al.
Publicado: (2022) -
Efficacy and Safety of Two Salts of Trientine in the Treatment of Wilson’s Disease
por: Woimant, France, et al.
Publicado: (2022) -
Dystonic Dysarthria in Wilson Disease: Efficacy of Zolpidem
por: Poujois, Aurélia, et al.
Publicado: (2017) -
High genetic carrier frequency of Wilson’s disease in France: discrepancies with clinical prevalence
por: Collet, Corinne, et al.
Publicado: (2018) -
Designing Clinical Trials in Wilson’s Disease
por: Ott, Peter, et al.
Publicado: (2021)